Calder Douglas W 4
4 · ACCENTIA BIOPHARMACEUTICALS INC · Filed Mar 2, 2012
Insider Transaction Report
Form 4
Calder Douglas W
VP Strategic Plan/Cap Markets
Transactions
- Award
Stock Option (Right to Buy)
2012-02-29+250,000→ 250,000 totalExercise: $0.44From: 2012-02-29Exp: 2022-03-01→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Exercise price is 100% of fair market value on date of grant.
- [F2]The options vested immediately on the date of grant.
- [F3]The options terminate 10 years from the grant date, or 90 days after the employee ceases to be an employee for any reason, other than death, disability or retirement.